France Vital Signs Monitoring Market Size, Share, and COVID-19 Impact Analysis, By Product (Wearable and Non-Wearable), By Indication (Cardiovascular Disorders, Diabetes, Pregnancy, Cancer, Respiratory Diseases, Movement Disorders, and Others), By End User (Hospitals, Ambulatory Health Centers, Home Care Settings, and Others), and France Vital Signs Monitoring Market Insights, Industry Trend, Forecasts to 2035

France Vital Signs Monitoring Market Insights Forecasts to 2035

• The France Vital Signs Monitoring Market Size Was Estimated at USD 360.2 Million in 2024.
• The France Vital Signs Monitoring Market Size is Expected to Grow at a CAGR of Around 7.9% from 2024 to 2035.
• The France Vital Signs Monitoring Market Size is Expected to Reach USD 830.9 Million By 2035.

According to a research report published by Spherical Insights & Consulting, the France Vital Signs Monitoring Market size is projected to reach USD 830.9 million by 2035, growing at a CAGR of 7.9% from 2025 to 2035. The French vital signs monitoring market is driven by the increasing prevalence of chronic diseases, a growing elderly population, and a greater adoption of remote patient monitoring and wearable technologies. Additionally, government and private sector investment in healthcare digitization, the demand for telehealth, and the shift towards home-based care are significant growth drivers

 Market Overview

The France Vital Signs Monitoring Market Size refers to the sector of the French healthcare industry that involves the development, production, and utilization of devices and systems designed to measure and monitor essential physiological parameters such as heart rate, blood pressure, respiratory rate, body temperature, and oxygen saturation in hospitals, clinics, and home-care settings. This market covers a wide range of technologies, including bedside monitors, wearable sensors, wireless systems, and remote monitoring solutions, and is driven by factors such as technological advancements, rising prevalence of chronic diseases, aging population, increasing demand for continuous and remote patient monitoring, and supportive government initiatives. The market plays a crucial role in enhancing patient care, enabling early detection of health issues, and supporting proactive clinical decision-making.

Report Coverage

This research report categorizes the market for the France vital signs monitoring market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France vital signs monitoring market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France vital signs monitoring market.

Driving Factors

The key drivers of the France vital signs monitoring market are the increasing prevalence of chronic diseases, a rapidly aging population, growing demand for home and remote patient monitoring, and advancements in technology like AI and wireless connectivity. These factors are creating a strong demand for both traditional and advanced devices for monitoring vital signs like blood pressure, temperature, pulse, and respiration. Support from the government through programs like SASN, PECAN, and France 2030 provides funding and support for these technologies. Finally, more awareness about preventive healthcare and devices that connect to hospital or home systems helps doctors make better decisions, boosting market growth.

Restraining Factors

Restraining factors for the France vital signs monitoring market include the high cost of advanced devices, leading to limited adoption by smaller facilities and individuals, and connectivity issues, which can hinder real-time data accuracy and transmission. Other restraints are the need for staff training to use complex equipment and inconsistent insurance coverage for advanced or home-based monitoring. 

Market Segmentation

The France vital signs monitoring market share is categorized by product, indication, and end user.

• The non-wearable segment accounted for the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The France vital signs monitoring market is segmented by product into wearable and non-wearable. Among these, the non-wearable segment accounted for the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The non-wearable segmental growth is due to its widespread use in hospitals and clinics, higher accuracy, ability to monitor multiple parameters simultaneously, and strong adoption in critical care and intensive care units (ICUs). Non-wearable monitors, such as bedside multiparameter monitors, are preferred in clinical settings because they provide continuous, real-time monitoring of vital signs like heart rate, blood pressure, respiratory rate, and oxygen saturation, which is crucial for managing critically ill patients.

• The cardiovascular disorders segment dominated the market in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

The France vital signs monitoring market is segmented by indication into cardiovascular disorders, diabetes, pregnancy, cancer, respiratory diseases, movement disorders, and others. Among these, the cardiovascular disorders segment dominated the market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The cardiovascular disorders’ segmental dominance is due to the high prevalence of heart-related conditions in France, the critical need for continuous monitoring of heart rate, blood pressure, and other vital parameters, increasing awareness about early detection and management of cardiovascular diseases, and the widespread use of monitoring devices in hospitals and home-care settings to prevent complications. Cardiovascular patients often require real-time tracking to manage conditions like hypertension, arrhythmia, and heart failure, making this segment the largest contributor to the market.

• The hospitals held the largest share in 2024 and are anticipated to grow at a significant CAGR during the forecast period.

The France vital signs monitoring market is segmented by end user into hospitals, ambulatory health centers, home care settings, and others. Among these, the hospitals segment held the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The hospital’s segmental growth is driven by the high patient volume, the need for continuous and real-time monitoring of critical patients, widespread adoption of advanced multiparameter monitoring systems, and the preference for non-wearable devices in intensive care units (ICUs) and emergency departments. Hospitals require reliable and accurate monitoring solutions to manage patients with chronic and acute conditions, making them the primary end users driving market demand.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France vital signs monitoring market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.   

List of Key Companies 

• Nonin Medical
• SunTech Medical
• Masimo Corp
• A&D Medical
• Nihon Kohden Corp
• OMRON Corp
• Medtronic PLC
• Koninklijke Philips NV
• GE HealthCare Technologies Inc
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)